Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?

NCT00571688 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00571688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00571688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?
Lead sponsor
Vanderbilt University
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2007
Completion date
February 28, 2009
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder